Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation

Circulation

Volumn 123, Issue 19, 2011, Pages 2077-2082

  Hussein, Ayman A ^a   Saliba, Walid I ^a   Martin, David O ^a   Shadman, Mazyar ^a   Kanj, Mohamed ^a   Bhargava, Mandeep ^a   Dresing, Thomas ^a   Chung, Mina ^a   Callahan, Thomas ^a   Baranowski, Bryan ^a   Tchou, Patrick ^a   Lindsay, Bruce D ^a   Natale, Andrea ^b   Wazni, Oussama M ^a,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b St David's Hospital   (United States)

^c Cardiac Pacing and Electrophysiology   (United States)

Author keywords

atrial fibrillation; catheter ablation; natriuretic peptides

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENT DISEASE;

AGED; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79957447833     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.007252     Document Type: Article

References (31)

1. Wyse DG Waldo AL DiMarco JP Domanski MJ Rosenberg Y Schron EB Kellen JC Greene HL Mickel MC Dalquist JE Corley SD; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825-1833.
2. Go AS Hylek EM Phillips KA Chang Y Henault LE Selby JV Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375.
3. Jourdain P Bellorini M Funck F Fulla Y Guillard N Loiret J Thebault B Sadeg N Desnos M. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study. Eur J Heart Fail. 2002;4:263-267.
4. Silvet H Young-Xu Y Walleigh D Ravid S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol. 2003;92: 1124-1127.
5. Arima M Kanoh T Kawano Y Oigawa T Yamagami S Matsuda S. Plasma levels of brain natriuretic peptide increase in patients with idiopathic bilateral atrial dilatation. Cardiology. 2002;97:12-17.
6. Inoue S Murakami Y Sano K Katoh H Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail. 2000;6:92-96.
7. Lee SH Jung JH Choi SH Lee N Park WJ Oh DJ Rhim CY Lee KH. Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J. 2006;70:100-104.
8. Li J Wang L. B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation. Heart Vessels. 2006;21:137-140.
9. Ellinor PT Low AF Patton KK Shea MA Macrae CA. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol. 2005;45:82-86.
10. Wang TJ Larson MG Levy D Benjamin EJ Leip EP Omland T Wolf PA Vasan RS. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655-663.
11. Patton KK Ellinor PT Heckbert SR Christenson RH DeFilippi C Gottdiener JS Kronmal RA. N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation. 2009;120:1768-1774.
12. Mollmann H Weber M Elsasser A Nef H Dill T Rixe J Schmitt J Sperzel J Hamm CW. NT-ProBNP predicts rhythm stability after cardioversion of lone atrial fibrillation. Circ J. 2008;72:921-925.
13. Rossi A Enriquez-Sarano M Burnett JC Jr Lerman A Abel MD Seward JB. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol. 2000;35: 1256-1262.
14. Yamada T Murakami Y Okada T Yoshida N Toyama J Yoshida Y Tsuboi N Inden Y Hirai M Murohara T. Plasma brain natriuretic peptide level after hybrid therapy with pulmonary vein isolation and antiarrhythmic drugs for atrial fibrillation. Int Heart J. 2008;49:143-151.
15. Yamada T Murakami Y Okada T Yoshida N Toyama J Yoshida Y Tsuboi N Inden Y Hirai M Murohara T. Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal persistent and permanent atrial fibrillation. Europace. 2007;9:770-774.
16. Date T Yamane T Inada K Matsuo S Miyanaga S Sugimoto K Shibayama K Taniguchi I Mochizuki S. Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation. Heart. 2006;92:1623-1627.
17. Kanj MH Wazni OM Natale A. How to do circular mapping catheterguided pulmonary vein antrum isolation: the Cleveland Clinic approach. Heart Rhythm. 2006;3:866-869.
18. Morrison LK Harrison A Krishnaswamy P Kazanegra R Clopton P Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 2002;39:202-209.
19. Rawlins ML Owen WE Roberts WL. Performance characteristics of four automated natriuretic peptide assays. Am J Clin Pathol. 2005;123: 439-445.
20. Oral H Knight BP Ozaydin M Tada H Chugh A Hassan S Scharf C Lai SW Greenstein R Pelosi F Jr Strickberger SA Morady F. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. J Am Coll Cardiol. 2002;40:100-104.
21. Cheung BM Kumana CR. Natriuretic peptides: relevance in cardiovascular disease. JAMA. 1998;280:1983-1984.
22. Levin ER Gardner DG Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321-328.
23. Maisel AS Krishnaswamy P Nowak RM McCord J Hollander JE Duc P Omland T Storrow AB Abraham WT Wu AH Clopton P Steg PG Westheim A Knudsen CW Perez A Kazanegra R Herrmann HC McCullough PA; Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
24. Tuinenburg AE Van Veldhuisen DJ Boomsma F Van Den Berg MP De Kam PJ Crijns HJ. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol. 1998;81:1207-1210.
25. Shelton RJ Clark AL Goode K Rigby AS Cleland JG. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Eur Heart J. 2006;27:2353-2361.
26. Knudsen CW Omland T Clopton P Westheim A Wu AH Duc P McCord J Nowak RM Hollander JE Storrow AB Abraham WT McCullough PA Maisel A. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol. 2005;46:838-844.
27. Skalidis EI Hamilos MI Karalis IK Chlouverakis G Kochiadakis GE Vardas PE. Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation. J Am Coll Cardiol. 2008;51:2053-2057.
28. Stiles MK John B Wong CX Kuklik P Brooks AG Lau DH Dimitri H Roberts-Thomson KC Wilson L De Sciscio P Young GD Sanders P. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor." J Am Coll Cardiol. 2009; 53:1182-1191.
29. Frustaci A Chimenti C Bellocci F Morgante E Russo MA Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96:1180-1184.
30. Hansson M. Natriuretic peptides in relation to the cardiac innervation and conduction system. Microsc Res Tech. 2002;58:378-386.
31. Herring N Zaman JA Paterson DJ. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway. Am J Physiol Heart Circ Physiol. 2001;281:H2318-H2327.